Just as Dr Green believes with rapamycin...if taken early enough will prevent Alzheimer's disease progression. I suspect that A 2-73 is a more targeted molecule, so no need for only once/week dosing as with rapamycin to prevent side effects. Some of Dr Green's patients have been on rapamycin for several years and he has told me that he has not seen a progression towards dementia for any of his ApoE4 carrier patients (nor any others I believe). This might be considered as a harbinger of what to expect with A 2-73 prescribed prophylactically.
News 
Market Data 
Discover 
